Streetbeat News

Analyst Ratings

ENLC

UBS analyst Shneur Gershuni initiates coverage on EnLink Midstream (NYSE:ENLC) with a Buy rating and announces a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 9:19 am

SNDX

BTIG analyst Justin Zelin maintains a Buy rating on Syndax Pharmaceuticals (NASDAQ:SNDX) and raises the price target from $34 to $35.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 9:16 am

SHW

BMO Capital analyst John McNulty upgraded Sherwin-Williams (NYSE:SHW) from Market Perform to Outperform and raised the price target from $269 to $275.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 9:16 am

MRNA

UBS analyst Eliana Merle upgraded Moderna (NASDAQ:MRNA) from Neutral to Buy and lowered the price target from $221 to $191.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 9:15 am

NWHUF

BMO Capital analyst Michael Markidis downgraded Northwest Healthcare REIT (OTC:NWHUF) from Outperform to Market Perform and lowered the price target from C$10 to C$7.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 9:14 am

GOOG

UBS analyst Lloyd Walmsley downgraded Alphabet (NASDAQ:GOOG) from Buy to Neutral and raised the price target from $123 to $132.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 9:12 am

ARVN

Oppenheimer analyst Mark Breidenbach assumes Arvinas (NASDAQ:ARVN) with an Outperform rating and announces a price target of $95.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 9:11 am

WES

UBS analyst Shneur Gershuni initiates coverage on Western Midstream (NYSE:WES) with a Neutral rating and announces a price target of $27.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 9:09 am

NRIX

Oppenheimer analyst Mark Breidenbach assumes Nurix Therapeutics (NASDAQ:NRIX) with an Outperform rating and announces a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 9:08 am

CE

BMO Capital analyst John McNulty downgraded Celanese (NYSE:CE) from Outperform to Market Perform and lowered the price target from $133 to $119.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 9:07 am